153 related articles for article (PubMed ID: 26968437)
1. Does ability to walk reflect general functionality in inflammatory neuropathies?
Draak TH; Gorson KC; Vanhoutte EK; van Nes SI; van Doorn PA; Cornblath DR; van den Berg LH; Faber CG; Merkies IS;
J Peripher Nerv Syst; 2016 Jun; 21(2):74-81. PubMed ID: 26968437
[TBL] [Abstract][Full Text] [Related]
2. Correlation of the patient's reported outcome Inflammatory-RODS with an objective metric in immune-mediated neuropathies.
Draak TH; Gorson KC; Vanhoutte EK; van Nes SI; van Doorn PA; Cornblath DR; van den Berg LH; Faber CG; Merkies IS;
Eur J Neurol; 2016 Jul; 23(7):1248-53. PubMed ID: 27129110
[TBL] [Abstract][Full Text] [Related]
3. Changing outcome in inflammatory neuropathies: Rasch-comparative responsiveness.
Draak TH; Vanhoutte EK; van Nes SI; Gorson KC; Van der Pol WL; Notermans NC; Nobile-Orazio E; Léger JM; Van den Bergh PY; Lauria G; Bril V; Katzberg H; Lunn MP; Pouget J; van der Kooi AJ; Hahn AF; Doorn PA; Cornblath DR; van den Berg LH; Faber CG; Merkies IS;
Neurology; 2014 Dec; 83(23):2124-32. PubMed ID: 25378677
[TBL] [Abstract][Full Text] [Related]
4. Rasch-built Overall Disability Scale (R-ODS) for immune-mediated peripheral neuropathies.
van Nes SI; Vanhoutte EK; van Doorn PA; Hermans M; Bakkers M; Kuitwaard K; Faber CG; Merkies IS
Neurology; 2011 Jan; 76(4):337-45. PubMed ID: 21263135
[TBL] [Abstract][Full Text] [Related]
5. Impairment measures versus inflammatory RODS in GBS and CIDP: a responsiveness comparison.
Vanhoutte EK; Draak TH; Gorson KC; van Nes SI; Hoeijmakers JG; Van der Pol WL; Notermans NC; Lewis RA; Nobile-Orazio E; Léger JM; Van den Bergh PY; Lauria G; Bril V; Katzberg H; Lunn MP; Pouget J; van der Kooi AJ; Hahn AF; van Doorn PA; Cornblath DR; van den Berg LH; Faber CG; Merkies IS;
J Peripher Nerv Syst; 2015 Sep; 20(3):289-95. PubMed ID: 26114893
[TBL] [Abstract][Full Text] [Related]
6. Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study.
Ruts L; Drenthen J; Jacobs BC; van Doorn PA;
Neurology; 2010 May; 74(21):1680-6. PubMed ID: 20427754
[TBL] [Abstract][Full Text] [Related]
7. Quality of life in inflammatory neuropathies: the IN-QoL.
Draak THP; Faber CG; Merkies ISJ;
J Neurol Neurosurg Psychiatry; 2018 Mar; 89(3):256-262. PubMed ID: 28986470
[TBL] [Abstract][Full Text] [Related]
8. Comparing the NIS vs. MRC and INCAT sensory scale through Rasch analyses.
Draak TH; Vanhoutte EK; van Nes SI; Gorson KC; Van der Pol WL; Notermans NC; Nobile-Orazio E; Lewis RA; Léger JM; Van den Bergh PY; Lauria G; Bril V; Katzberg H; Lunn MP; Pouget J; van der Kooi AJ; Hahn AF; van den Berg LH; van Doorn PA; Cornblath DR; Faber CG; Merkies IS;
J Peripher Nerv Syst; 2015 Sep; 20(3):277-88. PubMed ID: 26110493
[TBL] [Abstract][Full Text] [Related]
9. Improving fatigue assessment in immune-mediated neuropathies: the modified Rasch-built fatigue severity scale.
van Nes SI; Vanhoutte EK; Faber CG; Garssen M; van Doorn PA; Merkies IS;
J Peripher Nerv Syst; 2009 Dec; 14(4):268-78. PubMed ID: 20021568
[TBL] [Abstract][Full Text] [Related]
10. Defective Fas-mediated T-cell apoptosis predicts acute onset CIDP.
Comi C; Osio M; Ferretti M; Mesturini R; Cappellano G; Chiocchetti A; Carecchio M; Nascimbene C; Varrasi C; Cantello R; Mariani C; Monaco F; Dianzani U
J Peripher Nerv Syst; 2009 Jun; 14(2):101-6. PubMed ID: 19691532
[TBL] [Abstract][Full Text] [Related]
11. Patients with chronic inflammatory demyelinating polyneuropathy initially diagnosed as Guillain-Barré syndrome.
Odaka M; Yuki N; Hirata K
J Neurol; 2003 Aug; 250(8):913-6. PubMed ID: 12928908
[TBL] [Abstract][Full Text] [Related]
12. Differentiation Between Guillain-Barré Syndrome and Acute-Onset Chronic Inflammatory Demyelinating Polyradiculoneuritis-a Prospective Follow-up Study Using Ultrasound and Neurophysiological Measurements.
Grimm A; Oertl H; Auffenberg E; Schubert V; Ruschil C; Axer H; Winter N
Neurotherapeutics; 2019 Jul; 16(3):838-847. PubMed ID: 30756363
[TBL] [Abstract][Full Text] [Related]
13. Corticosteroids can help distinguish between Guillain-Barré syndrome and first attack of chronic inflammatory demyelinating neuropathy: an illustrative case report.
Alexander KJ; Alshubaili AF; Santhamoorthy P; Sharafuddin KM
Med Princ Pract; 2008; 17(5):422-4. PubMed ID: 18685286
[TBL] [Abstract][Full Text] [Related]
14. [Acute-Onset Chronic Inflammatory Demyelinating Polyradiculoneuropathy].
Kanbayashi T; Sonoo M
Brain Nerve; 2015 Nov; 67(11):1388-96. PubMed ID: 26560954
[TBL] [Abstract][Full Text] [Related]
15. Distinguishing acute-onset CIDP from Guillain-Barré syndrome with treatment related fluctuations.
Ruts L; van Koningsveld R; van Doorn PA
Neurology; 2005 Jul; 65(1):138-40. PubMed ID: 16009902
[TBL] [Abstract][Full Text] [Related]
16. Guillain-Barre or CIDP? That is the question.
Smith BE
Neurology; 2010 May; 74(21):1664-5. PubMed ID: 20445150
[No Abstract] [Full Text] [Related]
17. Electrodiagnostic criteria for acute and chronic inflammatory demyelinating polyradiculoneuropathy.
Van den Bergh PY; Piéret F
Muscle Nerve; 2004 Apr; 29(4):565-74. PubMed ID: 15052622
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory neuropathies.
Whitesell J
Semin Neurol; 2010 Sep; 30(4):356-64. PubMed ID: 20941668
[TBL] [Abstract][Full Text] [Related]
19. [Recent aspects of acute and chronic inflammatory polyneuropathies: Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy].
Pascual-Pascual SI
Rev Neurol; 2002 Aug 1-15; 35(3):269-76. PubMed ID: 12235589
[TBL] [Abstract][Full Text] [Related]
20. Acute-onset chronic inflammatory demyelinating polyneuropathy: An electrodiagnostic study.
Anadani M; Katirji B
Muscle Nerve; 2015 Nov; 52(5):900-5. PubMed ID: 25809534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
